FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064456854> ?p ?o ?g. }

• W2064456854 endingPage "98" @default.
• W2064456854 startingPage "93" @default.
• W2064456854 abstract "Background Existing drug therapies for paroxysmal supraventricular tachycardia (PSVT) have potentially serious adverse effects. Dofetilide, a pure class III antiarrhythmic agent, may offer an effective and safe alternative for treating PSVT. This study compared the efficacy and safety of dofetilide with that of propafenone and placebo in the prevention of PSVT. Methods This multicenter, randomized, placebo-controlled, parallel-group study compared the effectiveness of oral dofetilide 500 μg given twice daily with that of propafenone 150 mg given 3 times a day and placebo in preventing the recurrence of PSVT in 122 symptomatic patients. Episodes of PSVT were documented by symptom diaries and Hertcard (Hertford Medical, Hertfordshire, UK) event recorders. Results After 6 months of treatment, patients taking dofetilide, propafenone, and placebo had a 50%, 54%, and 6% probability, respectively, of remaining free of episodes of PSVT (P <.001 for both dofetilide and propafenone vs placebo). Both dofetilide and propafenone also decreased the frequency of episodes of PSVT; the median numbers of episodes in the dofetilide- and propafenone-treated groups were 1 and 0.5, respectively, compared with 5 in the placebo-treated group. Dofetilide was well tolerated; no proarrhythmia occurred. Three patients taking propafenone had serious treatment-related adverse effects that required drug discontinuation. Conclusions Dofetilide and propafenone were equally effective in preventing the recurrence of or decreasing the frequency of PSVT. (Am Heart J 2001;142:93-8.)" @default.
• W2064456854 created "2016-06-24" @default.
• W2064456854 creator A5001116231 @default.
• W2064456854 creator A5002733626 @default.
• W2064456854 creator A5007328218 @default.
• W2064456854 creator A5010337016 @default.
• W2064456854 creator A5017587338 @default.
• W2064456854 creator A5029308799 @default.
• W2064456854 creator A5052920250 @default.
• W2064456854 creator A5061239401 @default.
• W2064456854 creator A5073792258 @default.
• W2064456854 creator A5075969958 @default.
• W2064456854 creator A5085063493 @default.
• W2064456854 creator A5088339574 @default.
• W2064456854 date "2001-07-01" @default.
• W2064456854 modified "2023-10-13" @default.
• W2064456854 title "Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: A 6-month double-blind comparison with propafenone and placebo" @default.
• W2064456854 cites W1841210729 @default.
• W2064456854 cites W1969360791 @default.
• W2064456854 cites W1970906303 @default.
• W2064456854 cites W1984171219 @default.
• W2064456854 cites W2002374666 @default.
• W2064456854 cites W2008138428 @default.
• W2064456854 cites W2016275322 @default.
• W2064456854 cites W2047496300 @default.
• W2064456854 cites W2051199416 @default.
• W2064456854 cites W2070144304 @default.
• W2064456854 cites W2116317311 @default.
• W2064456854 cites W2154269614 @default.
• W2064456854 cites W2156484893 @default.
• W2064456854 cites W2314139393 @default.
• W2064456854 doi "https://doi.org/10.1067/mhj.2001.115439" @default.
• W2064456854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11431663" @default.
• W2064456854 hasPublicationYear "2001" @default.
• W2064456854 type Work @default.
• W2064456854 sameAs 2064456854 @default.
• W2064456854 citedByCount "35" @default.
• W2064456854 countsByYear W20644568542012 @default.
• W2064456854 countsByYear W20644568542013 @default.
• W2064456854 countsByYear W20644568542016 @default.
• W2064456854 countsByYear W20644568542017 @default.
• W2064456854 countsByYear W20644568542018 @default.
• W2064456854 countsByYear W20644568542019 @default.
• W2064456854 countsByYear W20644568542020 @default.
• W2064456854 crossrefType "journal-article" @default.
• W2064456854 hasAuthorship W2064456854A5001116231 @default.
• W2064456854 hasAuthorship W2064456854A5002733626 @default.
• W2064456854 hasAuthorship W2064456854A5007328218 @default.
• W2064456854 hasAuthorship W2064456854A5010337016 @default.
• W2064456854 hasAuthorship W2064456854A5017587338 @default.
• W2064456854 hasAuthorship W2064456854A5029308799 @default.
• W2064456854 hasAuthorship W2064456854A5052920250 @default.
• W2064456854 hasAuthorship W2064456854A5061239401 @default.
• W2064456854 hasAuthorship W2064456854A5073792258 @default.
• W2064456854 hasAuthorship W2064456854A5075969958 @default.
• W2064456854 hasAuthorship W2064456854A5085063493 @default.
• W2064456854 hasAuthorship W2064456854A5088339574 @default.
• W2064456854 hasConcept C118441451 @default.
• W2064456854 hasConcept C126322002 @default.
• W2064456854 hasConcept C142724271 @default.
• W2064456854 hasConcept C164705383 @default.
• W2064456854 hasConcept C197934379 @default.
• W2064456854 hasConcept C204787440 @default.
• W2064456854 hasConcept C27081682 @default.
• W2064456854 hasConcept C2777008848 @default.
• W2064456854 hasConcept C2777204175 @default.
• W2064456854 hasConcept C2777796741 @default.
• W2064456854 hasConcept C2779161974 @default.
• W2064456854 hasConcept C2780283014 @default.
• W2064456854 hasConcept C2781472538 @default.
• W2064456854 hasConcept C42219234 @default.
• W2064456854 hasConcept C71924100 @default.
• W2064456854 hasConceptScore W2064456854C118441451 @default.
• W2064456854 hasConceptScore W2064456854C126322002 @default.
• W2064456854 hasConceptScore W2064456854C142724271 @default.
• W2064456854 hasConceptScore W2064456854C164705383 @default.
• W2064456854 hasConceptScore W2064456854C197934379 @default.
• W2064456854 hasConceptScore W2064456854C204787440 @default.
• W2064456854 hasConceptScore W2064456854C27081682 @default.
• W2064456854 hasConceptScore W2064456854C2777008848 @default.
• W2064456854 hasConceptScore W2064456854C2777204175 @default.
• W2064456854 hasConceptScore W2064456854C2777796741 @default.
• W2064456854 hasConceptScore W2064456854C2779161974 @default.
• W2064456854 hasConceptScore W2064456854C2780283014 @default.
• W2064456854 hasConceptScore W2064456854C2781472538 @default.
• W2064456854 hasConceptScore W2064456854C42219234 @default.
• W2064456854 hasConceptScore W2064456854C71924100 @default.
• W2064456854 hasIssue "1" @default.
• W2064456854 hasLocation W20644568541 @default.
• W2064456854 hasLocation W20644568542 @default.
• W2064456854 hasOpenAccess W2064456854 @default.
• W2064456854 hasPrimaryLocation W20644568541 @default.
• W2064456854 hasRelatedWork W1981605787 @default.
• W2064456854 hasRelatedWork W2013939371 @default.
• W2064456854 hasRelatedWork W2099757539 @default.
• W2064456854 hasRelatedWork W2129084231 @default.
• W2064456854 hasRelatedWork W2184119888 @default.
• W2064456854 hasRelatedWork W2191797613 @default.

• next